JW Lifescience Corporation (KRX:234080)

Market Cap	170.33B -8.2%
Revenue (ttm)	253.71B +4.1%
Net Income	26.02B -47.4%
EPS	1,680.36 -47.4%
Shares Out	15.48M
PE Ratio	6.55
Forward PE	n/a
Dividend	500.00 (4.46%)
Ex-Dividend Date	Mar 31, 2026

Volume	6,129
Open	11,000
Previous Close	11,020
Day's Range	10,910 - 11,025
52-Week Range	10,550 - 15,580
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About JW Lifescience

JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 297
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 234080

Financial Performance

In 2025, JW Lifescience's revenue was 257.83 billion, an increase of 15.89% compared to the previous year's 222.48 billion. Earnings were 28.61 billion, a decrease of -34.97%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error